High dose rate and external beam radiotherapy in locally advanced prostate cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 32, Issue 2, 2009, Pages 187-190

  Viani, Gustavo Arruda ^a,b   Pellizzon, Antonio Cássio ^a   Guimarães, Flavio Silva ^a   Jacinto, Alexandre Arthur ^a   Dos Santos Novaes, Paulo Eduardo Ribeiro ^a   Salvajoli, João Vitor ^a  

^a Med Res Center Hospital do Cancer   (Brazil)

^b NONE   (Brazil)

Author keywords

Androgen hormonal deprivement; Brachytherapy; External beam radiotherapy; Locally advanced prostate cancer; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROSTATE ADENOCARCINOMA; PROTEIN BLOOD LEVEL; RADIATION DOSE; RADIATION RESPONSE; RECTUM HEMORRHAGE; URINARY URGENCY; URINE RETENTION; UROGENITAL TRACT DISEASE;

ADENOCARCINOMA; AGED; ANDROGEN ANTAGONISTS; BRACHYTHERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 67749084615     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181841f78     Document Type: Article

References (14)

1. D'Amico AV, Schultz D, Loffredo M, et al. Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for men with clinically localized prostate cancer. JAMA. 2000;284:1280-1283.
2. Bolla M, Gonsalez D, Warde P, et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med. 1997;337:295-300.
3. Pollack A, Zagars GK, Smith LG, et al. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol. 2000;18:3504-3911.
4. Zelefsky MJ, Fuks Z, Hunt M, et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol. 2001;166:876-881.
5. Mate TP, Gottesman JE, Hatton J, et al. High dose-rate afterloading 192Irid-ium prostate brachytherapy: feasibility report. Int J Radiat Oncol Biol Phys. 1998;41:525-533.
6. Kuban DA, Levy LB, Potters L, et al. Comparison of biochemical failure definitions for permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2006;65:1487-1493.
7. Vicini FA, Vargas C, Edmundson G, et al. The role of high dose rate brachytherapy in locally advanced prostate cancer. Semin Radiat Oncol. 2003;13:98.
8. Galalae RM, Martinez A, Mate T, et al. Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2004;58:1048.
9. Demanes DJ, Rodriguez RR, Schour L, et al. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10 year results. Int J Radiat Oncol Biol Phys. 2005;61:1306-1316.
10. Eulae SM, Van Hollebeke L, Cavanagh W, et al. High dose rate iridium 192 brachytherapy in localised prostate cancer: results and toxicity with maximum follow-up of 10 years [Abstract]. Int J Radiat Oncol Biol Phys. 2000; 48(suppl):149.
11. Pellizzon AC, Salvajoli JV, Maia MA, et al. Late urinary morbidity with high dose rate brachytherapy as a boost to conventional external beam radiation therapy for local and locally advanced prostate cancer. J Urol. 2004;171:1105.
12. Pilepich MV, Krall JM, Al-Sarraf M, et al. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology. 1995;45:616.
13. Bolla M, Gonzalez D, Warde P, et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med. 1997;337:295.
14. Martinez AA, Demanes DJ, Galalae R, et al. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regimen. Int J Radiat Oncol Biol Phys. 2005;62:1322.